Your session is about to expire
← Back to Search
Interventional Arm for Snoring
Study Summary
This trial evaluates the effectiveness of a mandibular device (MAD) vs conservative treatment for treating non-apneic snoring in adults, using CGI-I, ESS, SNORE-25, PSQI & CGI-S.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What risks are associated with the Interventional Arm procedure?
"In-depth analyses of Interventional Arm's safety gave it a score of 2, as the Phase 2 trial currently lacks evidence to support its efficacy but has some data backing up its security."
How many subjects have consented to the research?
"Affirmative, the information on clinicaltrials.gov reveals that this research is actively recruiting participants. The trial was first made available to the public on November 7th 2022 and had its most recent update issued March 1st 2023. It requires 120 patients across a single site."
Are there still vacancies available for enrollees in this research project?
"Affirmative. On clinicaltrials.gov, it is indicated that recruitment for this medicinal research is ongoing; the original post was on November 7th 2022 and has since been modified as recently as March 1st 2023. The trial requires 120 participants from a solitary site."
Share this study with friends
Copy Link
Messenger